The Cystic Fibrosis Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cystic Fibrosis Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cystic Fibrosis Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Cystic Fibrosis Therapeutics Market Report

Report Metric	Details
Report Name	Cystic Fibrosis Therapeutics Market
Segment by Type	CFTR Mucolytics PERT Anti-infectives Bronchodilators
Segment by Application	Hospitals Clinics
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Vertex Pharmaceuticals, F. Hoffmann-La Roche, AbbVie, Gilead Sciences, Novartis, AstraZeneca, Bayer, Celtaxsys, Pharmaxis, ProQR Therapeutics, PTC Therapeutics, Alcresta Therapeutics, Insmed Incorporated, Savara, Cyclacel Pharmaceuticals, Vectura, Allergan
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cystic Fibrosis Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cystic Fibrosis Therapeutics Market report?

Ans: The main players in the Cystic Fibrosis Therapeutics Market are Vertex Pharmaceuticals, F. Hoffmann-La Roche, AbbVie, Gilead Sciences, Novartis, AstraZeneca, Bayer, Celtaxsys, Pharmaxis, ProQR Therapeutics, PTC Therapeutics, Alcresta Therapeutics, Insmed Incorporated, Savara, Cyclacel Pharmaceuticals, Vectura, Allergan

What are the Application segmentation covered in the Cystic Fibrosis Therapeutics Market report?

Ans: The Applications covered in the Cystic Fibrosis Therapeutics Market report are Hospitals, Clinics

What are the Type segmentation covered in the Cystic Fibrosis Therapeutics Market report?

Ans: The Types covered in the Cystic Fibrosis Therapeutics Market report are CFTR, Mucolytics, PERT, Anti-infectives, Bronchodilators

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cystic Fibrosis Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 CFTR

1.2.3 Mucolytics

1.2.4 PERT

1.2.5 Anti-infectives

1.2.6 Bronchodilators

1.3 Market by Application

1.3.1 Global Cystic Fibrosis Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Clinics

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cystic Fibrosis Therapeutics Market Perspective (2019-2030)

2.2 Cystic Fibrosis Therapeutics Growth Trends by Region

2.2.1 Global Cystic Fibrosis Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Cystic Fibrosis Therapeutics Historic Market Size by Region (2019-2024)

2.2.3 Cystic Fibrosis Therapeutics Forecasted Market Size by Region (2025-2030)

2.3 Cystic Fibrosis Therapeutics Market Dynamics

2.3.1 Cystic Fibrosis Therapeutics Industry Trends

2.3.2 Cystic Fibrosis Therapeutics Market Drivers

2.3.3 Cystic Fibrosis Therapeutics Market Challenges

2.3.4 Cystic Fibrosis Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Cystic Fibrosis Therapeutics Players by Revenue

3.1.1 Global Top Cystic Fibrosis Therapeutics Players by Revenue (2019-2024)

3.1.2 Global Cystic Fibrosis Therapeutics Revenue Market Share by Players (2019-2024)

3.2 Global Cystic Fibrosis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Cystic Fibrosis Therapeutics Revenue

3.4 Global Cystic Fibrosis Therapeutics Market Concentration Ratio

3.4.1 Global Cystic Fibrosis Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cystic Fibrosis Therapeutics Revenue in 2023

3.5 Cystic Fibrosis Therapeutics Key Players Head office and Area Served

3.6 Key Players Cystic Fibrosis Therapeutics Product Solution and Service

3.7 Date of Enter into Cystic Fibrosis Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Cystic Fibrosis Therapeutics Breakdown Data by Type

4.1 Global Cystic Fibrosis Therapeutics Historic Market Size by Type (2019-2024)

4.2 Global Cystic Fibrosis Therapeutics Forecasted Market Size by Type (2025-2030)

5 Cystic Fibrosis Therapeutics Breakdown Data by Application

5.1 Global Cystic Fibrosis Therapeutics Historic Market Size by Application (2019-2024)

5.2 Global Cystic Fibrosis Therapeutics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Cystic Fibrosis Therapeutics Market Size (2019-2030)

6.2 North America Cystic Fibrosis Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Cystic Fibrosis Therapeutics Market Size by Country (2019-2024)

6.4 North America Cystic Fibrosis Therapeutics Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Cystic Fibrosis Therapeutics Market Size (2019-2030)

7.2 Europe Cystic Fibrosis Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Cystic Fibrosis Therapeutics Market Size by Country (2019-2024)

7.4 Europe Cystic Fibrosis Therapeutics Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Cystic Fibrosis Therapeutics Market Size (2019-2030)

8.2 Asia-Pacific Cystic Fibrosis Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Cystic Fibrosis Therapeutics Market Size by Region (2019-2024)

8.4 Asia-Pacific Cystic Fibrosis Therapeutics Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Cystic Fibrosis Therapeutics Market Size (2019-2030)

9.2 Latin America Cystic Fibrosis Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Cystic Fibrosis Therapeutics Market Size by Country (2019-2024)

9.4 Latin America Cystic Fibrosis Therapeutics Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Cystic Fibrosis Therapeutics Market Size (2019-2030)

10.2 Middle East & Africa Cystic Fibrosis Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Country (2019-2024)

10.4 Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Vertex Pharmaceuticals

11.1.1 Vertex Pharmaceuticals Company Detail

11.1.2 Vertex Pharmaceuticals Business Overview

11.1.3 Vertex Pharmaceuticals Cystic Fibrosis Therapeutics Introduction

11.1.4 Vertex Pharmaceuticals Revenue in Cystic Fibrosis Therapeutics Business (2019-2024)

11.1.5 Vertex Pharmaceuticals Recent Development

11.2 F. Hoffmann-La Roche

11.2.1 F. Hoffmann-La Roche Company Detail

11.2.2 F. Hoffmann-La Roche Business Overview

11.2.3 F. Hoffmann-La Roche Cystic Fibrosis Therapeutics Introduction

11.2.4 F. Hoffmann-La Roche Revenue in Cystic Fibrosis Therapeutics Business (2019-2024)

11.2.5 F. Hoffmann-La Roche Recent Development

11.3 AbbVie

11.3.1 AbbVie Company Detail

11.3.2 AbbVie Business Overview

11.3.3 AbbVie Cystic Fibrosis Therapeutics Introduction

11.3.4 AbbVie Revenue in Cystic Fibrosis Therapeutics Business (2019-2024)

11.3.5 AbbVie Recent Development

11.4 Gilead Sciences

11.4.1 Gilead Sciences Company Detail

11.4.2 Gilead Sciences Business Overview

11.4.3 Gilead Sciences Cystic Fibrosis Therapeutics Introduction

11.4.4 Gilead Sciences Revenue in Cystic Fibrosis Therapeutics Business (2019-2024)

11.4.5 Gilead Sciences Recent Development

11.5 Novartis

11.5.1 Novartis Company Detail

11.5.2 Novartis Business Overview

11.5.3 Novartis Cystic Fibrosis Therapeutics Introduction

11.5.4 Novartis Revenue in Cystic Fibrosis Therapeutics Business (2019-2024)

11.5.5 Novartis Recent Development

11.6 AstraZeneca

11.6.1 AstraZeneca Company Detail

11.6.2 AstraZeneca Business Overview

11.6.3 AstraZeneca Cystic Fibrosis Therapeutics Introduction

11.6.4 AstraZeneca Revenue in Cystic Fibrosis Therapeutics Business (2019-2024)

11.6.5 AstraZeneca Recent Development

11.7 Bayer

11.7.1 Bayer Company Detail

11.7.2 Bayer Business Overview

11.7.3 Bayer Cystic Fibrosis Therapeutics Introduction

11.7.4 Bayer Revenue in Cystic Fibrosis Therapeutics Business (2019-2024)

11.7.5 Bayer Recent Development

11.8 Celtaxsys

11.8.1 Celtaxsys Company Detail

11.8.2 Celtaxsys Business Overview

11.8.3 Celtaxsys Cystic Fibrosis Therapeutics Introduction

11.8.4 Celtaxsys Revenue in Cystic Fibrosis Therapeutics Business (2019-2024)

11.8.5 Celtaxsys Recent Development

11.9 Pharmaxis

11.9.1 Pharmaxis Company Detail

11.9.2 Pharmaxis Business Overview

11.9.3 Pharmaxis Cystic Fibrosis Therapeutics Introduction

11.9.4 Pharmaxis Revenue in Cystic Fibrosis Therapeutics Business (2019-2024)

11.9.5 Pharmaxis Recent Development

11.10 ProQR Therapeutics

11.10.1 ProQR Therapeutics Company Detail

11.10.2 ProQR Therapeutics Business Overview

11.10.3 ProQR Therapeutics Cystic Fibrosis Therapeutics Introduction

11.10.4 ProQR Therapeutics Revenue in Cystic Fibrosis Therapeutics Business (2019-2024)

11.10.5 ProQR Therapeutics Recent Development

11.11 PTC Therapeutics

11.11.1 PTC Therapeutics Company Detail

11.11.2 PTC Therapeutics Business Overview

11.11.3 PTC Therapeutics Cystic Fibrosis Therapeutics Introduction

11.11.4 PTC Therapeutics Revenue in Cystic Fibrosis Therapeutics Business (2019-2024)

11.11.5 PTC Therapeutics Recent Development

11.12 Alcresta Therapeutics

11.12.1 Alcresta Therapeutics Company Detail

11.12.2 Alcresta Therapeutics Business Overview

11.12.3 Alcresta Therapeutics Cystic Fibrosis Therapeutics Introduction

11.12.4 Alcresta Therapeutics Revenue in Cystic Fibrosis Therapeutics Business (2019-2024)

11.12.5 Alcresta Therapeutics Recent Development

11.13 Insmed Incorporated

11.13.1 Insmed Incorporated Company Detail

11.13.2 Insmed Incorporated Business Overview

11.13.3 Insmed Incorporated Cystic Fibrosis Therapeutics Introduction

11.13.4 Insmed Incorporated Revenue in Cystic Fibrosis Therapeutics Business (2019-2024)

11.13.5 Insmed Incorporated Recent Development

11.14 Savara

11.14.1 Savara Company Detail

11.14.2 Savara Business Overview

11.14.3 Savara Cystic Fibrosis Therapeutics Introduction

11.14.4 Savara Revenue in Cystic Fibrosis Therapeutics Business (2019-2024)

11.14.5 Savara Recent Development

11.15 Cyclacel Pharmaceuticals

11.15.1 Cyclacel Pharmaceuticals Company Detail

11.15.2 Cyclacel Pharmaceuticals Business Overview

11.15.3 Cyclacel Pharmaceuticals Cystic Fibrosis Therapeutics Introduction

11.15.4 Cyclacel Pharmaceuticals Revenue in Cystic Fibrosis Therapeutics Business (2019-2024)

11.15.5 Cyclacel Pharmaceuticals Recent Development

11.16 Vectura

11.16.1 Vectura Company Detail

11.16.2 Vectura Business Overview

11.16.3 Vectura Cystic Fibrosis Therapeutics Introduction

11.16.4 Vectura Revenue in Cystic Fibrosis Therapeutics Business (2019-2024)

11.16.5 Vectura Recent Development

11.17 Allergan

11.17.1 Allergan Company Detail

11.17.2 Allergan Business Overview

11.17.3 Allergan Cystic Fibrosis Therapeutics Introduction

11.17.4 Allergan Revenue in Cystic Fibrosis Therapeutics Business (2019-2024)

11.17.5 Allergan Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Vertex Pharmaceuticals

Alcresta Therapeutics

Insmed Incorporated

Savara

Cyclacel Pharmaceuticals

Vectura

Allergan plc

List of Tables

Table 1. Global Cystic Fibrosis Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of CFTR

Table 3. Key Players of Mucolytics

Table 4. Key Players of PERT

Table 5. Key Players of Anti-infectives

Table 6. Key Players of Bronchodilators

Table 7. Global Cystic Fibrosis Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Cystic Fibrosis Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Cystic Fibrosis Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Cystic Fibrosis Therapeutics Market Share by Region (2019-2024)

Table 11. Global Cystic Fibrosis Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Cystic Fibrosis Therapeutics Market Share by Region (2025-2030)

Table 13. Cystic Fibrosis Therapeutics Market Trends

Table 14. Cystic Fibrosis Therapeutics Market Drivers

Table 15. Cystic Fibrosis Therapeutics Market Challenges

Table 16. Cystic Fibrosis Therapeutics Market Restraints

Table 17. Global Cystic Fibrosis Therapeutics Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Cystic Fibrosis Therapeutics Market Share by Players (2019-2024)

Table 19. Global Top Cystic Fibrosis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cystic Fibrosis Therapeutics as of 2023)

Table 20. Ranking of Global Top Cystic Fibrosis Therapeutics Companies by Revenue (US$ Million) in 2023

Table 21. Global 5 Largest Players Market Share by Cystic Fibrosis Therapeutics Revenue (CR5 and HHI) & (2019-2024)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players Cystic Fibrosis Therapeutics Product Solution and Service

Table 24. Date of Enter into Cystic Fibrosis Therapeutics Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Cystic Fibrosis Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Cystic Fibrosis Therapeutics Revenue Market Share by Type (2019-2024)

Table 28. Global Cystic Fibrosis Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Cystic Fibrosis Therapeutics Revenue Market Share by Type (2025-2030)

Table 30. Global Cystic Fibrosis Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Cystic Fibrosis Therapeutics Revenue Market Share by Application (2019-2024)

Table 32. Global Cystic Fibrosis Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Cystic Fibrosis Therapeutics Revenue Market Share by Application (2025-2030)

Table 34. North America Cystic Fibrosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. North America Cystic Fibrosis Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 36. North America Cystic Fibrosis Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 37. Europe Cystic Fibrosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Europe Cystic Fibrosis Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 39. Europe Cystic Fibrosis Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 40. Asia-Pacific Cystic Fibrosis Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 41. Asia-Pacific Cystic Fibrosis Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 42. Asia-Pacific Cystic Fibrosis Therapeutics Market Size by Region (2025-2030) & (US$ Million)

Table 43. Latin America Cystic Fibrosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Latin America Cystic Fibrosis Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 45. Latin America Cystic Fibrosis Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 46. Middle East & Africa Cystic Fibrosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 48. Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 49. Vertex Pharmaceuticals Company Detail

Table 50. Vertex Pharmaceuticals Business Overview

Table 51. Vertex Pharmaceuticals Cystic Fibrosis Therapeutics Product

Table 52. Vertex Pharmaceuticals Revenue in Cystic Fibrosis Therapeutics Business (2019-2024) & (US$ Million)

Table 53. Vertex Pharmaceuticals Recent Development

Table 54. F. Hoffmann-La Roche Company Detail

Table 55. F. Hoffmann-La Roche Business Overview

Table 56. F. Hoffmann-La Roche Cystic Fibrosis Therapeutics Product

Table 57. F. Hoffmann-La Roche Revenue in Cystic Fibrosis Therapeutics Business (2019-2024) & (US$ Million)

Table 58. F. Hoffmann-La Roche Recent Development

Table 59. AbbVie Company Detail

Table 60. AbbVie Business Overview

Table 61. AbbVie Cystic Fibrosis Therapeutics Product

Table 62. AbbVie Revenue in Cystic Fibrosis Therapeutics Business (2019-2024) & (US$ Million)

Table 63. AbbVie Recent Development

Table 64. Gilead Sciences Company Detail

Table 65. Gilead Sciences Business Overview

Table 66. Gilead Sciences Cystic Fibrosis Therapeutics Product

Table 67. Gilead Sciences Revenue in Cystic Fibrosis Therapeutics Business (2019-2024) & (US$ Million)

Table 68. Gilead Sciences Recent Development

Table 69. Novartis Company Detail

Table 70. Novartis Business Overview

Table 71. Novartis Cystic Fibrosis Therapeutics Product

Table 72. Novartis Revenue in Cystic Fibrosis Therapeutics Business (2019-2024) & (US$ Million)

Table 73. Novartis Recent Development

Table 74. AstraZeneca Company Detail

Table 75. AstraZeneca Business Overview

Table 76. AstraZeneca Cystic Fibrosis Therapeutics Product

Table 77. AstraZeneca Revenue in Cystic Fibrosis Therapeutics Business (2019-2024) & (US$ Million)

Table 78. AstraZeneca Recent Development

Table 79. Bayer Company Detail

Table 80. Bayer Business Overview

Table 81. Bayer Cystic Fibrosis Therapeutics Product

Table 82. Bayer Revenue in Cystic Fibrosis Therapeutics Business (2019-2024) & (US$ Million)

Table 83. Bayer Recent Development

Table 84. Celtaxsys Company Detail

Table 85. Celtaxsys Business Overview

Table 86. Celtaxsys Cystic Fibrosis Therapeutics Product

Table 87. Celtaxsys Revenue in Cystic Fibrosis Therapeutics Business (2019-2024) & (US$ Million)

Table 88. Celtaxsys Recent Development

Table 89. Pharmaxis Company Detail

Table 90. Pharmaxis Business Overview

Table 91. Pharmaxis Cystic Fibrosis Therapeutics Product

Table 92. Pharmaxis Revenue in Cystic Fibrosis Therapeutics Business (2019-2024) & (US$ Million)

Table 93. Pharmaxis Recent Development

Table 94. ProQR Therapeutics Company Detail

Table 95. ProQR Therapeutics Business Overview

Table 96. ProQR Therapeutics Cystic Fibrosis Therapeutics Product

Table 97. ProQR Therapeutics Revenue in Cystic Fibrosis Therapeutics Business (2019-2024) & (US$ Million)

Table 98. ProQR Therapeutics Recent Development

Table 99. PTC Therapeutics Company Detail

Table 100. PTC Therapeutics Business Overview

Table 101. PTC Therapeutics Cystic Fibrosis Therapeutics Product

Table 102. PTC Therapeutics Revenue in Cystic Fibrosis Therapeutics Business (2019-2024) & (US$ Million)

Table 103. PTC Therapeutics Recent Development

Table 104. Alcresta Therapeutics Company Detail

Table 105. Alcresta Therapeutics Business Overview

Table 106. Alcresta Therapeutics Cystic Fibrosis Therapeutics Product

Table 107. Alcresta Therapeutics Revenue in Cystic Fibrosis Therapeutics Business (2019-2024) & (US$ Million)

Table 108. Alcresta Therapeutics Recent Development

Table 109. Insmed Incorporated Company Detail

Table 110. Insmed Incorporated Business Overview

Table 111. Insmed Incorporated Cystic Fibrosis Therapeutics Product

Table 112. Insmed Incorporated Revenue in Cystic Fibrosis Therapeutics Business (2019-2024) & (US$ Million)

Table 113. Insmed Incorporated Recent Development

Table 114. Savara Company Detail

Table 115. Savara Business Overview

Table 116. Savara Cystic Fibrosis Therapeutics Product

Table 117. Savara Revenue in Cystic Fibrosis Therapeutics Business (2019-2024) & (US$ Million)

Table 118. Savara Recent Development

Table 119. Cyclacel Pharmaceuticals Company Detail

Table 120. Cyclacel Pharmaceuticals Business Overview

Table 121. Cyclacel Pharmaceuticals Cystic Fibrosis Therapeutics Product

Table 122. Cyclacel Pharmaceuticals Revenue in Cystic Fibrosis Therapeutics Business (2019-2024) & (US$ Million)

Table 123. Cyclacel Pharmaceuticals Recent Development

Table 124. Vectura Company Detail

Table 125. Vectura Business Overview

Table 126. Vectura Cystic Fibrosis Therapeutics Product

Table 127. Vectura Revenue in Cystic Fibrosis Therapeutics Business (2019-2024) & (US$ Million)

Table 128. Vectura Recent Development

Table 129. Allergan Company Detail

Table 130. Allergan Business Overview

Table 131. Allergan Cystic Fibrosis Therapeutics Product

Table 132. Allergan Revenue in Cystic Fibrosis Therapeutics Business (2019-2024) & (US$ Million)

Table 133. Allergan Recent Development

Table 134. Research Programs/Design for This Report

Table 135. Key Data Information from Secondary Sources

Table 136. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Cystic Fibrosis Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Cystic Fibrosis Therapeutics Market Share by Type: 2023 VS 2030

Figure 3. CFTR Features

Figure 4. Mucolytics Features

Figure 5. PERT Features

Figure 6. Anti-infectives Features

Figure 7. Bronchodilators Features

Figure 8. Global Cystic Fibrosis Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Cystic Fibrosis Therapeutics Market Share by Application: 2023 VS 2030

Figure 10. Hospitals Case Studies

Figure 11. Clinics Case Studies

Figure 12. Cystic Fibrosis Therapeutics Report Years Considered

Figure 13. Global Cystic Fibrosis Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Cystic Fibrosis Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Cystic Fibrosis Therapeutics Market Share by Region: 2023 VS 2030

Figure 16. Global Cystic Fibrosis Therapeutics Market Share by Players in 2023

Figure 17. Global Top Cystic Fibrosis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cystic Fibrosis Therapeutics as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Cystic Fibrosis Therapeutics Revenue in 2023

Figure 19. North America Cystic Fibrosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Cystic Fibrosis Therapeutics Market Share by Country (2019-2030)

Figure 21. United States Cystic Fibrosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Cystic Fibrosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Cystic Fibrosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Cystic Fibrosis Therapeutics Market Share by Country (2019-2030)

Figure 25. Germany Cystic Fibrosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Cystic Fibrosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Cystic Fibrosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Cystic Fibrosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Cystic Fibrosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Cystic Fibrosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Cystic Fibrosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Cystic Fibrosis Therapeutics Market Share by Region (2019-2030)

Figure 33. China Cystic Fibrosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Cystic Fibrosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Cystic Fibrosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Cystic Fibrosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Cystic Fibrosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Cystic Fibrosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Cystic Fibrosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Cystic Fibrosis Therapeutics Market Share by Country (2019-2030)

Figure 41. Mexico Cystic Fibrosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Cystic Fibrosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Cystic Fibrosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Cystic Fibrosis Therapeutics Market Share by Country (2019-2030)

Figure 45. Turkey Cystic Fibrosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Cystic Fibrosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Vertex Pharmaceuticals Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2019-2024)

Figure 48. F. Hoffmann-La Roche Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2019-2024)

Figure 49. AbbVie Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2019-2024)

Figure 50. Gilead Sciences Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2019-2024)

Figure 51. Novartis Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2019-2024)

Figure 52. AstraZeneca Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2019-2024)

Figure 53. Bayer Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2019-2024)

Figure 54. Celtaxsys Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2019-2024)

Figure 55. Pharmaxis Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2019-2024)

Figure 56. ProQR Therapeutics Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2019-2024)

Figure 57. PTC Therapeutics Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2019-2024)

Figure 58. Alcresta Therapeutics Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2019-2024)

Figure 59. Insmed Incorporated Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2019-2024)

Figure 60. Savara Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2019-2024)

Figure 61. Cyclacel Pharmaceuticals Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2019-2024)

Figure 62. Vectura Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2019-2024)

Figure 63. Allergan Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2019-2024)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-12J14669

Tue Apr 30 00:00:00 UTC 2024

Add to Cart

Global Pharmaceutical and Consumer Products Coding Equipment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-32H12616

Tue Apr 30 00:00:00 UTC 2024

Add to Cart

Global Pharmaceutical Co-Packing Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-13K12891

Tue Apr 30 00:00:00 UTC 2024

Add to Cart

Global Nucleic Acid-based Drugs Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-27P12567

Tue Apr 30 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Cystic Fibrosis Therapeutics Market Research Report 2024

Published Date: January 2024

Report Code: QYRE-Auto-39S13839

Global Cystic Fibrosis Therapeutics Market Research Report 2024

FEATURED COMPANIES

Cystic Fibrosis Therapeutics Market

Scope of Cystic Fibrosis Therapeutics Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Cystic Fibrosis Therapeutics Market report?

What are the Application segmentation covered in the Cystic Fibrosis Therapeutics Market report?

What are the Type segmentation covered in the Cystic Fibrosis Therapeutics Market report?

FEATURED COMPANIES

RELATED REPORTS